After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Galectin Therapeutics Inc is $363.22M. A total of 0.57 million shares were traded on the day, compared to an average of 311.13K shares.
In the most recent transaction, 10X Fund, L.P. sold 50,000 shares of GALT for 4.94 per share on Oct 22 ’25. After the transaction, the 10% Owner now owns 5,872,207 company shares. In a previous transaction on Sep 12 ’25, CALLICUTT JACK W sold 8,706 shares at 6.44 per share. GALT shares that Chief Financial Officer owns now total 7,614.
Among the insiders who sold shares, LEWIS JOEL disposed of 14,000 shares on Sep 12 ’25 at a per-share price of $6.36. This resulted in the President and CEO holding 832,592 shares of GALT after the transaction. In another insider transaction, LEWIS JOEL bought 54,250 shares at $6.36 per share on Sep 12 ’25.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, GALT has a high of $6.55 and a low of $0.73.
As of this writing, GALT has an earnings estimate of -$0.11 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of -$0.11 per share and a lower estimate of -$0.11. The company reported an EPS of -$0.18 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. GALT’s latest balance sheet shows that the firm has $39.65M in Cash & Short Term Investments as of fiscal 2021. There were $29.06M in debt and $9.03M in liabilities at the time. Its Book Value Per Share was -$1.86, while its Total Shareholder’s Equity was $2.62M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GALT is Buy with a score of 4.00.
